Prying into the Origins of Disease, Experts Gather at YSPH for Scientific Imaging Symposium
Many of tomorrow’s biggest health advances will depend on the tiniest bits of evidence today. To explore the latest trends, obstacles and successes in the biosciences, where success hangs on seeing things a few microns (or smaller) in size, the Department of Environmental Health Sciences at the Yale School of Public Health hosted a daylong symposium (November 22) on mass spectrometry that drew experts from industry and academia to compare how they are using imaging technology to pry ever deeper into the mysteries of biology—and disease.
YSPH International Olive Oil and Health Symposium to be Held in Legendary City of Delphi
Taking a cue from the ancient Greeks and their deep respect for the olive tree and the oil produced from its fruit, researchers led by the Yale School of Public Health are hosting a symposium in December in the legendary city of Delphi to explore the many human and planetary health benefits associated with the olive tree and its products.
Yale School of Public Health symposium on lifetime exposures and human health: the exposome; summary and future reflections
The exposome is defined as “the totality of environmental exposures encountered from birth to death” and was developed to address the need for comprehensive environmental exposure assessment to better understand disease etiology.Source: Human Genomics
Yale prof raises concerns about potential health hazards of recreational marijuana
NEW HAVEN >> Recreational marijuana use has been approved in Massachusetts starting in 2018, and there is an effort for it to be legalized in Connecticut, but a Yale School of Public Health professor is warning of cannabis’ potential hazards.Source: New Haven Register
Yale Research Provides Insights into Alcoholic Liver Disease
A new study from the Yale School of Public Health has identified a novel mechanism that protects the liver against the accumulation of fats and may represent a promising new therapeutic approach for treating and/or preventing alcoholic liver disease (ALD) and other fatty liver diseases.
Dr. Donna Spiegelman, Director of Yale’s Center for Methods in Implementation and Prevention Science, Receives Grant to Support Community Organizations in Ending the HIV Epidemic
To strengthen the quality of, and technical expertise available to, projects funded by federal agencies as part of Ending the HIV Epidemic: A Plan for America (EHE), Donna Spiegelman, ScD, Director of the Yale School of Public Health’s Center for Methods in Implementation and Prevention Science (CMIPS), has been awarded the NIH grant “R3EDI: Rigorous, Rapid, & Relevant Evidence aDaptation & Implementation to Ending the HIV Epidemic.”
Who should inform the public on the president’s health? Yale Biomedical Ethics expert weighs in
Patient-physician confidentiality is a fundamental principle of medical ethics. In an interview with WTNH, Sarah Hull, MD, the associate director of the Program for Biomedical Ethics, discusses how physicians should balance obligations toward individual patients with the duty to promote public health and preserve public trust.Source: WTNH
YSPH Researchers Find that Vitamin D Supplementation Does Not Lower Children’s Risk of TB Infection
Yale faculty members Drs. Xin Zhou and Donna Spiegelman at the Center for Methods in Implementation and Prevention Science and Department of Biostatistics at the Yale School of Public Health, along with colleagues from several other universities, including lead author Dr. Davaasambuu Ganmaa of the Harvard T. H. Chan School of Public Health, published findings last week in the New England Journal of Medicine, demonstrating that vitamin D supplementation does not lower children’s risk of TB infection.
Surge in single-use PPE feeds "toxic" pandemic waste crisis
The global response to the COVID-19 pandemic produced millions of articles of single-use personal protective equipment (PPE). Without proper disposal, many items end up in traditional waste streams or dumped in the open. Reusable PPE, Dr. Jodi Sherman notes, may provide a solution.Source: Financial Times